Immune interactions in malaria co-infections with other endemic infectious diseases: implications for the development of improved disease interventions

Microbes and Infection

Volumn 10, Issue 9, 2008, Pages 948-952

  Troye Blomberg, Marita ^a   Berzins, Klavs ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Co infections; Immunology; Malaria

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL INFECTION; BURKITT LYMPHOMA; CELLULAR IMMUNITY; CYTOKINE RELEASE; ENDEMIC DISEASE; EPSTEIN BARR VIRUS; ESCHERICHIA COLI; HELMINTH; HOST PARASITE INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; KLEBSIELLA; MALARIA; MEROZOITE; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SALMONELLA; SCHISTOSOMA MANSONI; STAPHYLOCOCCUS AUREUS; WORM INFECTION;

ANIMALS; BACTERIAL INFECTIONS; DISEASE MANAGEMENT; ENDEMIC DISEASES; EPSTEIN-BARR VIRUS INFECTIONS; HELMINTHIASIS; HIV INFECTIONS; HUMANS; MALARIA; VIRUS DISEASES;

EID: 53549125796     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2008.07.014     Document Type: Article

References (62)

1. Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., and Hay S.I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434 (2005) 214-217
2. Druilhe P., Tall A., and Sokhna C. Worms can worsen malaria: towards a new means to roll back malaria?. Trends Parasitol. 21 (2005) 359-362
3. Hotez P., Molyneux D.H., Stillwaggon E., Bentwich Z., and Kumaresan J. Neglected tropica diseases and HIV/AIDS. Lancet 368 (2006) 1865-1866
4. Brooker S., Clements A.C., Hotez P.J., Hay S.I., Tatem A.J., Bundy D.A., and Snow R.W. The co-distribution of Plasmodium falciparum and hookworm among African schoolchildren. Malaria J 5 (2006) 99
5. Kjetland E.F., Ndhlovu P.D., Gomo E., Mduluza T., Midzi N., Gwanzura L., Mason P.R., Sandvik L., Friis H., and Gundersen S.G. Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS 20 (2006) 593-600
6. Borkow G., and Bentwich Z. HIV and helminth co-infection: is deworming necessary?. Parasite Immunol. 28 (2006) 605-612
7. Molyneux D.H., Hotez P.J., and Fenwick A. "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med. 2 (2005) 1064-1070
8. Mathers C.D., Ezzati M., and Lopez A.D. Measuring the burden of neglected tropical diseases: the Global Burden of Diseases framework. PLoS Negl. Trop. Dis. 1 (2007) e114
9. Hotez P.J., Molyneux D.H., Fenwick A., Ottesen E., Sachs S.E., and Sachs J.D. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis and malaria: a comprehensive pro-poor health policy and strategy for the developing world. PLos Med. 3 (2006) 576-584
10. Perlmann P., and Troye-Blomberg M. Malaria and the immune system in human. In: Perlmann P., and Troye-Blomberg M. (Eds). Chem. Immunol (2002), Karger, Basel 229-242
11. Marsh K., and Kinyanjui S. Immune effector mechanisms in malaria. Parasite Immunol. 28 (2006) 51-60
12. Riley E.M., Wahl S., Perkins D.J., and Schofield L. Regulating immunity to malaria. Parasite Immunol. 28 (2006) 35-49
13. Bouharoun-Tayon H., and Druilhe P. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect. Immun. 60 (1992) 1473-1481
14. Aribot G., Rogier C., Sarthou J.L., Trape J.F., Balde A.T., Druilhe P., and Roussilhon C. Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, West Africa). Am. J. Trop. Med. Hyg. 54 (1996) 449-457
15. Taylor R.R., Allen S.J., Greenwood B.M., and Riley E.M. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am. J. Trop. Med. Hyg. 58 (1998) 406-413
16. Good M.F. Identification of early cellular immune factors regulating growth of malaria parasites in humans. Immunity 23 (2005) 241-242
17. Stevenson M.M., and Urban B.C. Antigen presentation and dendritic cell biology in malaria. Parasite Immunol. 28 (2006) 5-14
18. Walther M., Tongren J.E., Andrews L., Korbel D., King E., Fletcher H., Andersen R.F., Bejon P., Thompson F., Dunachie S.J., Edele F., de Souza J.B., Sinden R.E., Gilbert S.C., Riley E.M., and Hill A.V. Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 23 (2005) 287-296
19. Hisaeda H., Tetsutani K., Imai T., Moriya C., Tu L., Hamano S., Duan X., Chou B., Ishida H., Aramaki A., Shen J., Ishii K.J., Coban C., Akira S., Takeda K., Yasutomo K., Torii M., and Himeno K. Malaria parasites require TLR9 signaling for immune evasion by activating regulatory T cells. J. Immunol. 180 (2008) 2496-2503
20. Maizels R.M., Balic A., Gomez-Escobar N., Nair M., Taylor M., and Allen J.E. Helminth parasites - masters of regulation. Immunol. Rev. 201 (2004) 89-116
21. Loukas A., and Prociv P. Immune responses in hookworm infections. Clin. Microbiol. 14 (2001) 689-703
22. Maizels R., and Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat. Rev. Immunol. 3 (2003) 733-744
23. Taylor M.D., Legoff L., Harris A., Malone E., Allen J.E., and Maizels R.M. Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J. Immunol. 174 (2005) 4924-4933
24. Hartgers F.C., and Yazdanbakhsh M. Co-infection of helminths and malaria: modulation of the immune response to malaria. Parasite Immunol. 28 (2006) 497-506
25. Helmby H., Kullberg M., and Troye-Blomberg M. Altered immune responses in mice with concomitant Schistosoma mansoni and Plasmodium chabaudi infections. Infect. Immun. 66 (1998) 5167-5174
26. Yoshida A., Maruyama H., Kumagai T., Amano T., Kobayashi F., Zhang M., Himeno K., and Ohta N. Schistosoma mansoni infection cancels the susceptibility to Plasmodium chabaudi through induction of type 1 immune responses in A/J mice. Int. Immunol. 12 (2000) 1117-1125
27. Helmby H., Perlmann H., Troye-Blomberg M., and Perlmann P. Immunoglobulin E elevation in Plasmodium chabaudi malaria. Infect. Immun. 64 (1996) 1432-1433
28. Naus C.W.A., Jones F.M., Satti M.Z., Joseph S., Riley E.M., Kimani G., Mwatha J.K., Kariuki C.H., Ouma J.H., Kabatereine N.B., Vennervald B.J., and Dunne D.W. Serological responses among individuals in areas where both schistosomiasis and malaria are endemic: cross reactivity between Schistosoma mansoni and Plasmodium falciparum. J. Infect. Dis. 187 (2003) 1272-1282
29. Pierrot C., Wilson S., Lallet H., Lafitte S., Jones F.M., Daher W., Capron M., Dunne D.W., and Khalife J. Identification of a novel antigen of Schistosoma mansoni shared with Plasmodium falciparum and evaluation of different cross-reactive antibody subclasses induced by human schistosomiasis and malaria. Infect. Immun. 74 (2006) 3347-3354
30. Mutapi F., Roussilhon C., Mduluza T., and Druilhe P. Anti-malaria humoral responses in children exposed to Plasmodium falciparum and Schistosoma haematobium. Mem. Inst. Oswaldo Cruz 102 (2007) 405-409
31. Spiegel A., Tall A., Raphenon G., Trape J.-F., and Druilhe P. Increased frequency of malaria attacks in subjects co-infected by intestinal worms and Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 97 (2003) 198-199
32. Sokhna C., Le Hesran J.-Y., Mbaye P.A., Akiana J., Camara P., Diop M., Ly A., and Druilhe P. Increase of malaria attacks among children presenting concomitant infection by Schistosoma mansoni in Senegal. Malaria J 3 (2004) 43
33. Lyke K.E., Dicko A., Dabo A., Sangare L., Kone A., Coulibaly D., Guindo A., Traore K., Daou M., Diarra L., Sztein M.B., Plowe C.W., and Doumbo O.K. Association of Schistosoma haematobium infection with protection against acute Plasmodium falciparum malaria in Malian children. Am. J. Trop. Med. Hyg. 73 (2005) 1124-1130
34. Shapiro A.E., Tukahebwa E.M., Kasten J., Clarke S.E., Magnussen P., Olsen A., Kabatereine N.B., Ndyomugyenyi R., and Brooker S. Epidemiology of helminth infections and their relationship to clinical malaria in Uganda. Trans. R. Soc. Trop. Med. Hyg. 99 (2005) 18-24
35. Muturi E.J., Mbogo C.M., Mwangangi J.M., Ng'ang'a Z.W., Kabiru E.W., Mwandawiro C., and Beier J.C. Concomitant infections of Plasmodium falciparum and Wuchereria bancrofti on the Kenyan coast. Filaria J. 5 (2006) 8
36. Bejon P., Mwangi T.W., Lowe B., Peshu N., Hill A.V.S., and Marsh K. Helminth infection and eosinophilia and the risk of Plasmodium falciparum malaria in 1- to 6-year old children in a malaria endemic area. PLoS Negl. Trop. Dis. 2 (2008) e164
37. Nacher M., Gay F., Singhasivanon P., Krudsood S., Treeprasertsuk S., Mazier D., Vouldoukis I., and Looareesuwan S. Ascaris lumbricoides infection is associated with protection from cerebral malaria. Parasite Immunol. 22 (2000) 107-113
38. Nacher M., Singhasivanon P., Silachamroon U., Treeprasertsuk S., Vannaphan S., Traore B., Gay F., and Looareesuwan S. Helminth infections are associated with protection from malaria-related acute renal failure and jaundice in Thailand. Am. J. Trop. Med. Hyg. 65 (2001) 834-836
39. Briand V., Watier L., Le Hesran J.-Y., Garcia A., and Cot M. Coinfection with Plasmodium falciparum and Schistosoma haematobium: protective effect of schistosomiasis on malaria in Senegalese children?. Trends Parasitol. 72 (2005) 702-707
40. Perlmann H., Helmby H., Hagstedt M., Carlsson J., Larsson P.H., Troye-Blomberg M., and Perlmann P. IgE elevation and IgE anti-malaria antibodies in Plasmodium falciparum malaria: association of high levels with cerebral malaria. Clin. Exp. Immunol. 97 (1994) 284-292
41. Perlmann P., Perlmann H., Wåhlin Flyg B., Hagstedt M., ElGhazali G., Worku S., Fernandez V., Rutta A.S.M., and Troye-Blomberg M. Immunoglobulin E, a pathogenic factor in Plasmodium falciparum malaria. Infect. Immun. 65 (1997) 116-121
42. Bereczky S., Montgomery S.M., Troye-Blomberg M., Rooth I., Shaw M.A., and Färnert A. Elevated anti-malarial IgG in asymptomatic individuals is associated with reduced risk for subsequent clinical malaria. Int. J. Parasitol. 34 (2004) 935-942
43. Cohen J.I. Epstein-Barr virus infection. N. Eng. J. Med. 343 (2000) 481-492
44. Rickinson A.E., and Kieff E. Epstein-Barr virus. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology (2001), Lippincott Williams and Wilkins, Philadelphia, PA 2575-2628
45. Epstein M.A. Burkitt's lymphoma: clues to the role of malaria. Nature 312 (1984) 398
46. Lam K.M., Syed N., Whittle H., and Crawford D.H. Circulating Epstein-Barr virus-carrying B cells in acute malaria. Lancet 337 (1991) 876-878
47. Whittle H.C., Brown J., Marsh K., Greenwood B.M., Seidelin P., Tighe H., and Wedderburn L. T-cell control of Epstein-Barr-virus-infected B cells is lost during P. falciparum malaria. Nature 312 (1984) 449-450
48. Whittle H.C., Brown J., Marsh K., Blackman M., Jobe O., and Shenton F. The effects of Plasmodium falciparum malaria on immune control of B lymphocytes in Gambian children. Clin. Exp. Immunol. 80 (1990) 213-218
49. Rochford R., Cannon M.J., and Moormann A.M. Endemic Burkitt's lymphoma: a polymicrobial disease?. Nat. Rev. Microbiol. 3 (2005) 182-187
50. Brombacher F., Kastelein R.A., and Alber G. Novel IL12 family members shed light on the orchestration of Th1 responses. Trends Immunol. 24 (2003) 207-212
51. Donati D., Espmark E., Kironde F., Mbidde E.K., Kamya M., Lundkvist A., Wahlgren M., Bejarano M.T., and Falk K.I. Clearance of circulating Epstein-Barr virus DNA in children with acute malaria after antimalaria treatment. J. Infect. Dis. 193 (2006) 971-977
52. Yone C.L.R.P., Kube D., Kremsner P., and Luty A.J.F. Persistent Epstein-Barr viral reactivation in young African children with a history of severe Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 100 (2006) 669-676
53. Rasti N., Falk K.I., Donati D., Gyan B.A., Goka B.Q., Troye-Blomberg M., Akanmori B.D., Kurtzhals J.A.L., Dodoo D., Consolini R., Linde A., Wahlgren M., and Bejarano M.T. Circulating Epstein-Barr virus in children living in malaria-endemic areas. Scand. J. Immunol. 61 (2005) 461-465
54. Chene A., Donati D., Guerreiro-Cacais A.O., Levitsky V., Chen Q., Falk K.I., Orem J., Kironde F., Wahlgren M., and Bejarano M.T. A molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathogens 3 (2007) e80
55. UNAIDS/WHO. AIDS Epidemic update (2005), UNAIDS/World Health Organization, Geneva
56. Feinberg M.B. Changing the natural history of HIV disease. Lancet 348 (1996) 239-246
57. Fauci A.S., Mavilio D., and Kottilil S. NK cells in HIV infection: paradigm for protection of targets for ambush. Nat. Rev. Immunol. 5 (2005) 835-843
58. Juompan L., Lambin P., and Zouali M. Selective alterations of the antibody response to HIV-1. Appl. Biochem. Biotechnol 75 (1998) 139-150
59. Butcher G.A. HIV and malaria: a lesson in immunology?. Parasitol. Today 8 (1992) 307-311
60. Rowlands-Jones S.L., and Lohman B. Interactions between malaria and HIV infection - an emerging public health problem?. Microbes Infect. 4 (2002) 1265-1270
61. Whitworth J.A., and Hewitt K.A. Effect of malaria on HIV-1 progression and transmission. Lancet 365 (2005) 196-197
62. Rénia L., and Potter S.M. Co-infection of malaria with HIV: an immunological perspective. Parasite Immunol. 28 (2006) 589-595